Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trial watch
Laura Senovilla, Erika Vacchelli, Pauline Garcia, et al.
OncoImmunology (2013) Vol. 2, Iss. 4, pp. e23803-e23803
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Classification of current anticancer immunotherapies
Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, et al.
Oncotarget (2014) Vol. 5, Iss. 24, pp. 12472-12508
Open Access | Times Cited: 440
Trial watch: IDO inhibitors in cancer therapy
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
OncoImmunology (2014) Vol. 3, Iss. 10, pp. e957994-e957994
Open Access | Times Cited: 288
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Yuchen Fan, James J. Moon
Vaccines (2015) Vol. 3, Iss. 3, pp. 662-685
Open Access | Times Cited: 255
Trial watch
Erika Vacchelli, Alexander Eggermont, Catherine Sautès‐Fridman, et al.
OncoImmunology (2013) Vol. 2, Iss. 6, pp. e24612-e24612
Open Access | Times Cited: 250
Trial watch
Erika Vacchelli, Ilio Vitale, Alexander Eggermont, et al.
OncoImmunology (2013) Vol. 2, Iss. 10, pp. e25771-e25771
Open Access | Times Cited: 244
Clinical potential of electroporation for gene therapy and DNA vaccine delivery
Laure Lambricht, Alessandra Lopes, Špela Kos, et al.
Expert Opinion on Drug Delivery (2015) Vol. 13, Iss. 2, pp. 295-310
Closed Access | Times Cited: 214
Trial Watch
Erika Vacchelli, Alexander Eggermont, Catherine Sautès‐Fridman, et al.
OncoImmunology (2013) Vol. 2, Iss. 8, pp. e25238-e25238
Open Access | Times Cited: 147
Trial Watch
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
OncoImmunology (2014) Vol. 3, Iss. 3, pp. e27878-e27878
Open Access | Times Cited: 138
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
Aitziber Buqué, Norma Bloy, Fernando Aranda, et al.
OncoImmunology (2015) Vol. 4, Iss. 4, pp. e1008814-e1008814
Open Access | Times Cited: 121
Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase
Xiuwen Guan, Jie Chen, Yingying Hu, et al.
Biomaterials (2018) Vol. 171, pp. 198-206
Closed Access | Times Cited: 112
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles
Ahlam Ali, Cian M. McCrudden, Joanne McCaffrey, et al.
Nanomedicine Nanotechnology Biology and Medicine (2016) Vol. 13, Iss. 3, pp. 921-932
Open Access | Times Cited: 103
Vectors and strategies for nonviral cancer gene therapy
Jessica Pahle, Wolfgang Walther
Expert Opinion on Biological Therapy (2015) Vol. 16, Iss. 4, pp. 443-461
Closed Access | Times Cited: 99
Nanoparticle cancer vaccines: Design considerations and recent advances
Jingjing Liu, Lei Miao, Jiying Sui, et al.
Asian Journal of Pharmaceutical Sciences (2019) Vol. 15, Iss. 5, pp. 576-590
Open Access | Times Cited: 89
An Overview of Nanomaterial Applications in Pharmacology
Madhura Roy, Arpita Roy, Sarvesh Rustagi, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 23
Digital Pathology for Better Clinical Practice
Assia Hijazi, Carlo Bifulco, Paméla Baldin, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1686-1686
Open Access | Times Cited: 13
Trial Watch
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, et al.
OncoImmunology (2013) Vol. 2, Iss. 12, pp. e26621-e26621
Open Access | Times Cited: 100
Trial Watch
Erika Vacchelli, Ilio Vitale, Éric Tartour, et al.
OncoImmunology (2013) Vol. 2, Iss. 9, pp. e25595-e25595
Open Access | Times Cited: 91
Trial Watch
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
OncoImmunology (2014) Vol. 3, Iss. 1, pp. e27048-e27048
Open Access | Times Cited: 80
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Aglaia Pappa, et al.
Pharmacology & Therapeutics (2016) Vol. 165, pp. 32-49
Closed Access | Times Cited: 80
Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
Venkataswarup Tiriveedhi, Natalia Tucker, John M. Herndon, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 23, pp. 5964-5975
Open Access | Times Cited: 79
ImmTACs for targeted cancer therapy: Why, what, how, and which
Joanne Oates, Namir J. Hassan, Bent K. Jakobsen
Molecular Immunology (2015) Vol. 67, Iss. 2, pp. 67-74
Closed Access | Times Cited: 79
Trial Watch
Erika Vacchelli, Alexander Eggermont, Wolf H. Fridman, et al.
OncoImmunology (2013) Vol. 2, Iss. 5, pp. e24238-e24238
Open Access | Times Cited: 76
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Valeria Rolih, Giuseppina Barutello, Selina Iussich, et al.
Journal of Translational Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 66
Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy
Salima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top